DNA Content in Non-Hodgkin's Lymphoma
Author Information
Author(s): R.A. Cowan, M. Harris, M. Jones, D. Crowther
Primary Institution: Christie Hospital and Holt Radium Institute
Hypothesis
What is the prognostic significance of DNA ploidy and proliferative activity in high and intermediate grade non-Hodgkin's lymphoma?
Conclusion
DNA ploidy is not significantly associated with clinical outcomes, but proliferative activity correlates with histological subtype and response to therapy.
Supporting Evidence
- 51% of tumors were diploid, while 49% were non-diploid.
- A significant association was observed between proliferative index and histological subtype.
- 71% of patients with a low proliferative index achieved complete remission compared to 49% with a high index.
- Proliferative activity varied significantly between different histological subtypes.
Takeaway
This study looked at DNA in cancer cells from patients with a type of lymphoma to see if it could help predict how well they would do with treatment. It found that while DNA type didn't help much, how fast the cancer cells were growing did matter.
Methodology
Flow cytometric analysis was performed on tumor tissue from patients to estimate DNA content and proliferative activity.
Limitations
The study may have limitations due to the retrospective nature and the potential for sampling error.
Participant Demographics
{"age_range":"15-75","median_age":51,"gender":null}
Statistical Information
P-Value
{"ploidy":null,"proliferative_index":0.023,"overall_survival":null}
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website